Secondary Logo

Institutional members access full text with Ovid®

Thymic Stromal Lymphopoietin-Related Allergic Pathway in Patients With Vernal Keratoconjunctivitis

Zhang, Zong-Duan, MD, PhD; Deng, Yu-Xuan, MD; Ma, Hui-Xiang, MD; Chen, Xiao-Gang, MD; Chen, Lin-Hua, MD; Qu, Jia, MD

doi: 10.1097/ICO.0000000000001832
Basic Investigation

Purpose: To investigate the expression of thymic stromal lymphopoietin (TSLP) and the relevant signaling pathways in the giant papillae obtained from patients with vernal keratoconjunctivitis (VKC) and to study the potential functional role and molecular mechanism of TSLP.

Methods: Giant papillae from VKC patients and control samples were used to perform immunohistochemical staining and analyze the mRNA expression of TSLP and related pathway by real-time polymerase chain reaction.

Results: TSLP was markedly expressed in the epithelial cells and some inflammatory cells of giant papillae, but not in the control conjunctival tissue. TSLP mRNA expression in the giant papillae of VKC was increased by 9.63 ± 0.99 (mean ± SD) fold compared with controls (P < 0.01). CD11c+ and OX40L+ immunoreactive cells largely infiltrated the giant papillae as observed by immunohistochemical staining. CD4+Th2 cell infiltration was observed through high immunoreactivity of CD4. Th2 cytokines (IL-4, IL-5 and IL-13) and OX40 in the VKC specimens showed increased expression. Augmented gene expression levels of CD4 (6.88 ± 1.84), OX40L (7.60 ± 1.79), OX40 (7.25 ± 1.38), IL-4 (6.89 ± 1.46), IL-5 (8.42 ± 1.55), and IL-13 (9.69 ± 1.94) were significantly different from controls (P < 0.05).

Conclusions: Our observations provide strong evidence that TSLP may be a crucial factor that contributes to the development and progression of allergic conjunctivitis. The results also demonstrated that TSLP activates dendritic cells to prime CD4+T cells to differentiate into Th2 type and triggers Th2-dominant allergic inflammation through the TSLP/OX40L/OX40 signaling as part of immunopathogenesis of VKC.

Eye Hospital of Wenzhou Medical University, Wenzhou, China.

Correspondence: Jia Qu, MD, Eye Hospital of Wenzhou Medical University, 270 Xueyuan Rd, Wenzhou, ZheJiang, China 325027 (e-mail:

Supported by the Bureau of Science and Technology of Wen Zhou, Zhe Jiang, China (grant no. Y20150075).

The authors have no conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (

Received May 26, 2018

Accepted November 01, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.